Award

DK077961

Funder: National Institute of Diabetes and Digestive and Kidney Diseases

Funded outputs count: 8

Funder award ID: DK077961

OpenAlex ID: G6561176210

B cells promote hepatic inflammation, biliary cyst formation, and salivary gland inflammation in the NOD.c3c4 model of autoimmune cholangitis

2011 · Yuki Moritoki, Masanobu Tsuda, et al. · Cellular Immunology · 23

Deletion of Interleukin-6 in Mice With the Dominant Negative Form of Transforming Growth Factor β Receptor II Improves Colitis but Exacerbates Autoimmune Cholangitis

2010 · Weici Zhang, Masanobu Tsuda, et al. · Hepatology · 30

B‐cell depletion with anti‐CD20 ameliorates autoimmune cholangitis but exacerbates colitis in transforming growth factor‐β receptor II dominant negative mice†

2009 · Yuki Moritoki, Zhe‐Xiong Lian, et al. · Hepatology · 98

Deletion of interleukin-12p40 suppresses autoimmune cholangitis in dominant negative transforming growth factor β receptor type II mice #

2009 · Katsunori Yoshida, Guo-Xiang Yang, et al. · Hepatology · 117

β-Glucosylceramide ameliorates liver inflammation in murine autoimmune cholangitis

2009 · W Zhang, Y Moritoki, et al. · Clinical & Experimental Immunology · 17

B Cells Suppress the Inflammatory Response in a Mouse Model of Primary Biliary Cirrhosis

2008 · Yuki Moritoki, Weici Zhang, et al. · Gastroenterology · 80

Deficiency in regulatory T cells results in development of antimitochondrial antibodies and autoimmune cholangitis #

2008 · Weici Zhang, Rahul Sharma, et al. · Hepatology · 101

Differential mechanisms in the pathogenesis of autoimmune cholangitis versus inflammatory bowel disease in interleukin‐2Rα−/− mice†

2008 · Willy Hsu, Weici Zhang, et al. · Hepatology · 81